Rural Ohioans struggling with opioid addiction often can't get a proven medication to treat it, not because it doesn't work, but because their local doctors have never been trained to prescribe it. A nearly $1 million federal study aims to change that.
Researchers are launching a randomized clinical trial across 40 rural primary care clinics in Ohio and West Virginia to test whether a structured training and mentorship program can get more doctors prescribing buprenorphine, a medication that reduces cravings, prevents withdrawal, and significantly lowers overdose risk for people with opioid use disorder.
The $982,736 grant from the Department of Health and Human Services funds the expanded trial, which builds on a smaller pilot conducted at 29 federally qualified health centers in Ohio. That early work showed promising signs but wasn't large enough to draw firm conclusions.
The core challenge the study addresses is straightforward: buprenorphine works, but rural primary care clinics are among the least likely places to find a doctor prescribing it. Stigma around the medication, limited training opportunities, and the isolation of small rural practices all play a role. The program being tested pairs clinical training with stigma reduction and then keeps doctors connected to peer mentors over the long term, since rural clinics rarely have specialists nearby to consult.
Primary care doctors are a natural target for this kind of intervention. They already see patients who need addiction treatment, and a primary care setting carries less social stigma than a specialized addiction clinic, which may make patients more willing to seek help.
Beyond measuring how many doctors adopt buprenorphine prescribing, the trial will track patient outcomes: how many stay in treatment, how many achieve remission, and whether infectious disease rates tied to drug use decline. Researchers will also interview clinic staff and leadership to understand what makes the program work or stall, with an eye toward eventually scaling it to rural communities outside Ohio and West Virginia.
Similar efforts to build addiction care capacity in underserved populations are underway elsewhere, including a program in Kentucky focused on women leaving prison and a South Carolina study testing treatments for teens with addiction and trauma. Results from the Ohio trial, expected to inform whether the training model can be rolled out nationally, are likely several years away given the long-term follow-up built into the study design.
